[Acute effect of a new alpha 1-receptor blocking drug, E-643, on severe congestive heart failure--pharmacokinetic and hemodynamic studies].
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C018176:bunazosin